BioFactura Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BioFactura Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3044
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioFactura Inc (Biofactura) is a manufacturer of biosimilars that discovers, develops and markets biodefense drugs and client selected novel drugs. The company provides contract services such as process development, stable cell lines, manufacturing, and others. Its stable cell line offers stable mammalian cell line development for high titer, scalable manufacture of monoclonal antibodies and recombinant proteins, among others. Biofactura provides biodefence products such as smallpox therapeutic, and ebola sudan therapeutic. The company utilizes its stablefast biomanufacturing platform, which is a novel system to generate stable NS0 cell lines for biopharmaceutical manufacturing. It caters biodefense and non-biodefense markets. Biofactura is headquartered in Frederick, Maryland, the US.

BioFactura Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioFactura Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioFactura Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioFactura Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioFactura Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioFactura Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BioFactura Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
BioFactura Raises USD1.8 Million in Series A Financing 10
Partnerships 11
BioFactura Partners with Geneva Foundation 11
Noble Life Sciences Partners with BioFactura 12
Licensing Agreements 13
Vivalis Enters Into Licensing Agreement With Biofactura For EB66 Cell Line 13
BioFactura Inc – Key Competitors 14
BioFactura Inc – Key Employees 15
BioFactura Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
BioFactura Inc, Pharmaceuticals & Healthcare, Key Facts 2
BioFactura Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioFactura Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioFactura Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioFactura Inc, Deals By Therapy Area, 2012 to YTD 2018 8
BioFactura Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BioFactura Raises USD1.8 Million in Series A Financing 10
BioFactura Partners with Geneva Foundation 11
Noble Life Sciences Partners with BioFactura 12
Vivalis Enters Into Licensing Agreement With Biofactura For EB66 Cell Line 13
BioFactura Inc, Key Competitors 14
BioFactura Inc, Key Employees 15

List of Figures
BioFactura Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioFactura Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioFactura Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioFactura Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioFactura Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioFactura Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioFactura Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioFactura Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[BioFactura Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Jumbo SA:企業の戦略・SWOT・財務分析
    Jumbo SA - Strategy, SWOT and Corporate Finance Report Summary Jumbo SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Global Clean Energy Holdings Inc:企業の戦略的SWOT分析
    Global Clean Energy Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • EOH Holdings Ltd (EOH):企業の財務・戦略的SWOT分析
    EOH Holdings Ltd (EOH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Emerald Health Therapeutics Inc (EMH):製薬・医療:M&Aディール及び事業提携情報
    Summary Emerald Health Therapeutics Inc (Emerald Health), formerly T-Bird Pharma Inc, is a producer of pharmaceutical grade medical cannabis. The company extracts and markets dried cannabis, and cannabis oils and capsules. It offers cannabinoid medicines, which are present in an unparalleled opportu …
  • InDex Pharmaceuticals Holding AB (INDEX):企業の財務・戦略的SWOT分析
    Summary InDex Pharmaceuticals Holding AB (InDex Pharmaceuticals) is a pharmaceutical company that offers treatments for immunological diseases. The company’s lead compound cobitolimod, currently in the phase 2 stage, is intended for the treatment of moderate to severe treatment active refractory ulc …
  • Curevac AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Curevac AG (Curevac), formerly CureVac GmbH is a clinical-stage biopharmaceutical company that develops RNA-based medicines. The company develops, designs, and produces messenger RNA molecules for therapeutic and prophylactic vaccines in the fields of oncology and infectious diseases. Its RN …
  • Pretium Packaging, L.L.C.:企業の戦略・SWOT・財務分析
    Pretium Packaging, L.L.C. - Strategy, SWOT and Corporate Finance Report Summary Pretium Packaging, L.L.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Itausa – Investimentos Itau S.A.:企業の戦略・SWOT・財務情報
    Itausa - Investimentos Itau S.A. - Strategy, SWOT and Corporate Finance Report Summary Itausa - Investimentos Itau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Clientele Limited
    Clientele Limited - Strategy, SWOT and Corporate Finance Report Summary Clientele Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Garvan Institute of Medical Research-製薬・医療分野:企業M&A・提携分析
    Summary Garvan Institute of Medical Research (Garvan Institute) is a biomedical institute that offers research services. The institute conducts research in the fields of cancer, diabetes and obesity, Alzheimer’s and Parkinson’s disease, asthma, rheumatoid arthritis, osteoporosis, arthritis and pitui …
  • Plymouth Tube Company:企業の戦略的SWOT分析
    Plymouth Tube Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Ciber, Inc.:企業の戦略・SWOT・財務情報
    Ciber, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ciber, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • CS Communication & Systemes SA:企業の戦略・SWOT・財務分析
    CS Communication & Systemes SA - Strategy, SWOT and Corporate Finance Report Summary CS Communication & Systemes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • InVivo Therapeutics Corp:企業の製品パイプライン分析2018
    Summary InVivo Therapeutics Corp (InVivo), a subsidiary of InVivo Therapeutics Holdings Corp, is a medical device company that offers therapeutic products. The company develops and commercializes groundbreaking treatments for spinal cord injuries. Its products include biocompatible neuro spinal scaf …
  • Petro Caribbean Resources Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Petro Caribbean Resources Ltd (Petro Caribbean Resources) is an oil and gas exploration and development company that offers oil and gas exploration and development of petroleum and natural gas reserves. The company owns and operates oil and gas assets located in Putumayo Basin, Colombia. It …
  • Southern Petrochemical Industries Corp Ltd (SPIC):企業の財務・戦略的SWOT分析
    Summary Southern Petrochemical Industries Corp Ltd (SPIC) is a chemical company that manufactures fertilizers for agriculture. The company offers products such as chemical fertilizer, organic and water soluble fertilizers, plant growth regulators, micro nutrients, and industrial products. Its chemic …
  • Trustpower Limited:企業の戦略的SWOT分析
    Trustpower Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Duravit AG:企業の戦略・SWOT・財務情報
    Duravit AG - Strategy, SWOT and Corporate Finance Report Summary Duravit AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Erytech Pharma SA (ERYP):企業の財務・戦略的SWOT分析
    Summary Erytech Pharma SA (Erytech) is a clinical-stage biopharmaceutical company that provides development of therapies for rare forms of cancer and orphan diseases. The company develops pipeline of product candidates through its proprietary ERYCAPS platform. It offers product candidates which are …
  • Healthcare Locums Ltd:企業の戦略的SWOT分析
    Healthcare Locums Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆